Price T Rowe Associates Inc. MD Has $6.10 Million Stock Position in Ambev S.A. (NYSE:ABEV)

Price T Rowe Associates Inc. MD trimmed its position in Ambev S.A. (NYSE:ABEV - Free Report) by 10.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,297,220 shares of the company's stock after selling 382,700 shares during the period. Price T Rowe Associates Inc. MD's holdings in Ambev were worth $6,100,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also recently bought and sold shares of the company. NewEdge Advisors LLC boosted its stake in shares of Ambev by 51.4% in the fourth quarter. NewEdge Advisors LLC now owns 17,084 shares of the company's stock worth $32,000 after acquiring an additional 5,798 shares during the last quarter. IFP Advisors Inc boosted its position in Ambev by 7.5% in the 4th quarter. IFP Advisors Inc now owns 84,868 shares of the company's stock valued at $157,000 after buying an additional 5,900 shares during the period. Mondrian Investment Partners LTD increased its holdings in Ambev by 40.4% during the 4th quarter. Mondrian Investment Partners LTD now owns 20,810 shares of the company's stock worth $38,000 after purchasing an additional 5,993 shares during the period. Stephens Inc. AR raised its holdings in Ambev by 3.6% in the fourth quarter. Stephens Inc. AR now owns 173,066 shares of the company's stock valued at $320,000 after acquiring an additional 6,078 shares in the last quarter. Finally, Jones Financial Companies Lllp lifted its position in shares of Ambev by 7.8% during the 4th quarter. Jones Financial Companies Lllp now owns 85,142 shares of the company's stock worth $158,000 after purchasing an additional 6,164 shares during the last quarter. Hedge funds and other institutional investors own 8.13% of the company's stock.

Ambev Trading Up 1.0 %

ABEV stock traded up $0.03 during midday trading on Tuesday, reaching $2.49. 19,626,370 shares of the company's stock traded hands, compared to its average volume of 28,962,999. The business has a 50-day moving average price of $2.31 and a two-hundred day moving average price of $2.12. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.20 and a quick ratio of 0.89. Ambev S.A. has a fifty-two week low of $1.76 and a fifty-two week high of $2.59. The company has a market capitalization of $39.16 billion, a P/E ratio of 13.81, a PEG ratio of 5.80 and a beta of 0.80.

Ambev (NYSE:ABEV - Get Free Report) last issued its quarterly earnings data on Wednesday, February 26th. The company reported $0.05 EPS for the quarter, missing analysts' consensus estimates of $0.06 by ($0.01). The firm had revenue of $4.63 billion during the quarter, compared to analyst estimates of $22.42 billion. Ambev had a return on equity of 16.12% and a net margin of 17.02%. Equities research analysts forecast that Ambev S.A. will post 0.18 EPS for the current fiscal year.

Ambev Cuts Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, April 14th. Investors of record on Tuesday, March 18th were paid a $0.0221 dividend. The ex-dividend date was Tuesday, March 18th. This represents a $0.09 dividend on an annualized basis and a yield of 3.55%. Ambev's dividend payout ratio (DPR) is 52.94%.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on ABEV. UBS Group downgraded shares of Ambev from a "buy" rating to a "neutral" rating in a research report on Tuesday, April 22nd. Bank of America lowered Ambev from a "buy" rating to a "neutral" rating in a research note on Friday, January 17th. Morgan Stanley downgraded shares of Ambev from an "equal weight" rating to an "underweight" rating in a report on Monday, April 7th. Barclays dropped their price objective on Ambev from $2.50 to $2.00 and set an "equal weight" rating for the company in a research report on Tuesday, January 21st. Finally, StockNews.com initiated coverage on Ambev in a research report on Wednesday, April 23rd. They issued a "buy" rating for the company. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $2.45.

About Ambev

Ambev SA, through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, carbonated soft drinks, malt and food, other alcoholic beverages, and non-alcoholic and non-carbonated products in Brazil, Central America and Caribbean, Latin America South, and Canada. It offers beer primarily under the Skol, Brahma, Antarctica, Brahva, Budweiser, Bud Light, Beck, Leffe, Hoegaarden, Balboa ICE, Balboa, Atlas Golden Light, Atlas, Bucanero, Cristal, Mayabe, Presidente, Presidente Light, Brahma Light, Bohemia, The One, Corona, Modelo Especial, Stella Artois, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Cusqueña, Michelob Ultra, Busch, Pilsen, Ouro Fino, Bud 66, Banks, Deputy, Patricia, Labatt Blue, Alexander Keith's, and Kokanee brands.